Public Consultation on the assessment of co-dependent technology chapter of the draft revised Pharmaceutical Benefits Advisory Committee (PBAC) Guidelines

Page last updated: 6 May 2016

Public Submissions

The call for submissions to the public consultation process for the draft assessment of co‑dependent technology chapter of the draft revised PBAC Guidelines closed on 11 April 2016. The Department appreciates the contribution of all organisation and individuals who made a submission.

The submissions have been provided to the Guidelines Review Steering Committee for consideration in the finalisation of the revised PBAC Guidelines.


Unless otherwise requested, all submissions to the Review have been published on this page.

The Department of Health has not published submissions, or parts of submissions, that contain personal information, offensive language, potentially defamatory material or copyright infringing material.

Responsibility for copyright in submissions resides with the author(s), not with the Department of Health.

All submissions have been converted to Portable Document Format (PDF) for publication and may have a different appearance to the document that was submitted.

Your submission and contact details have been stored in accordance with the Australian Privacy Principles from Schedule 1 of the Privacy Amendment (Enhancing Privacy Principles) Act 2012 and the Archives Act 2012.  Should you have any concerns about the storage of your submission, or if you wish to gain access to make a correction, please email the PBS Post Market Review team. A copy of the Department’s privacy policy is available on request. If you wish to make a complaint about the handling of your private information, you may contact the Department of Health Privacy Contact Officer on 02 6289 5773 and, if unsatisfied with the response, you may submit a complaint to the Office of the Australian Information Commissioner.


  • The views expressed in submissions published on this website are solely those of the contributing authors or organisations.
  • The Commonwealth accepts no responsibility for the completeness or accuracy of any information contained in the submissions.
  • The Commonwealth makes no representations about the suitability of the information for any particular purpose. Users of the information must make their own inquiries and assessments about those matters or seek independent advice.
  • Submissions are published on the understanding that the contributing authors or organisations have copyright in the submissions either by way of ownership or a licence. They retain their copyright, and by making submissions they licence the Commonwealth to publish the submissions, unless a party when making a submission has requested that it be kept confidential and the Commonwealth clearly agrees that the submission will be kept confidential.


Table of Submissions


Author Name

Document Link

Date received


Industry Organisation

Not for publication



Evaluator Group

Not for publication



Medicines Australia

Submission 3 (PDF 439KB)



Pfizer Australia

Submission 4 (PDF 208KB)